Literature DB >> 28355325

Estrogen receptor-alpha gene XbaI A > G polymorphism influences short-term cognitive decline in healthy oldest-old individuals.

Amanda Caroline Silva Chaves1, Vanessa Gomes Fraga1, Henrique Cerqueira Guimarães2, Antonio Lucio Teixeira2, Maira Tonidandel Barbosa2, Maria das Graças Carvalho1, Ana Paula Lucas Mota1, Ieda de Fátima Oliveira Silva1, Paulo Caramelli2, Karina Braga Gomes1, Patrícia Nessralla Alpoim1.   

Abstract

METHODS: The individuals were categorized in two groups according to the presence or absence of cognitive decline. Cognitive data were related to genetic information.
RESULTS: The XbaI -351 AA genotype was more common among cognitive decliners, while -351G allele carriers showed cognitive stability or improvement.
CONCLUSION: These results suggest that ESR-1 could be associated with one-year cognitive decline in healthy oldest-old individuals, since the estrogen pathway may be involved with neuroprotection, even in healthy brain aging.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28355325     DOI: 10.1590/0004-282X20170018

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  3 in total

1.  Oestrogen receptor α gene polymorphisms, insomnia, and cognitive functions in perimenopausal and postmenopausal women in non-manual employment.

Authors:  Iwona Bojar; Dorota Raczkiewicz; Mariusz Gujski; Ewa Humeniuk; Artur Wdowiak; Alfred Owoc; Jarosław Pinkas
Journal:  Arch Med Sci       Date:  2020-05-07       Impact factor: 3.707

Review 2.  Contribution of Inhibitor of Differentiation and Estrogenic Endocrine Disruptors to Neurocognitive Disorders.

Authors:  Andrea Avecilla; Mayur Doke; Jeremy Jovellanos; Vincent Avecilla
Journal:  Med Sci (Basel)       Date:  2018-08-03

3.  Genetic and non-genetic factors associated with the phenotype of exceptional longevity & normal cognition.

Authors:  Bin Han; Huashuai Chen; Yao Yao; Xiaomin Liu; Chao Nie; Junxia Min; Yi Zeng; Michael W Lutz
Journal:  Sci Rep       Date:  2020-11-05       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.